J. Fernando Bazan
Chief Technology Officer
Biophysics
BioTechne
United States of America
Biography
Dr. J. Fernando Bazan was appointed Chief Technology Officer when he joined the Company on August 1, 2013. Following training at Stanford, Berkeley, and UCSF in biochemistry and biophysics, he led very active groups in biotherapeutics discovery as a senior scientist at DNAX Research Institute (now Merck Research Labs) and at Genentech (Roche). He also served as Chief Scientific Officer at NeuroScience, a neuroimmunology diagnostics startup. Dr. Bazan holds an adjunct faculty appointment in the Dept. of Pharmacology at the University of Minnesota School of Medicine.
Research Interest
NeuroScience, a neuroimmunology,biochemistry and biophysics